\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\:\\	on\\ his\\ trunk\\,\\ buttocks\\,\\ and\\ posterior\\ surfaces\\ of\\ upper\\ and\\ lower\\ extremities\\ there\\ were\\ 1\\-4\\ mm\\ soft\\,\\ yellow\\ papules\\ on\\ an\\ erythematous\\ base\\.\\ there\\ were\\ no\\ plaque\\-type\\ lesions\\ present\\ over\\ the\\ elbows\\,\\ knees\\ or\\ fingers\\.\\ abdomen\\ was\\ soft\\ and\\ non\\ tender\\.\\ the\\ corneas\\ were\\ clear\\.\\ laboratory\\:\\	fasting\\ lipid\\ profile\\ was\\ significant\\ for\\ triglycerides\\ 5582\\,\\ total\\ cholesterol\\ 1025\\ and\\ a\\ milky\\ white\\ uppermost\\ layer\\ was\\ noted\\ in\\ the\\ blood\\ collection\\ tube\\.\\ clinical\\ course\\:\\ after\\ a\\ referral\\ to\\ internal\\ medicine\\,\\ the\\ patient\\ was\\ started\\ on\\ gemfibrozil\\.\\ over\\ the\\ following\\ 6\\ weeks\\,\\ his\\	skin\\ lesions\\ resolved\\ and\\ his\\ triglycerides\\ dropped\\ to\\ under\\ 500\\.\ \(0\)\
\-\ after\\ a\\ referral\\ to\\ internal\\ medicine\\,\\ the\\ patient\\ was\ \(0\)\
\-\ started\\ on\\ gemfibrozil\\.\\ over\\ the\\ following\\ 6\\ weeks\\,\\ his\ \(0\)\
\-\ skin\\ lesions\\ resolved\\ and\\ his\\ triglycerides\\ dropped\\ to\ \(2\)\
\-\ under\\ 500\\.\ \(2\)\
\-\ eruptive\\ xanthoma\\ \\(1997\\ uniformed\\ services\\ dermatology\\ seminar\\,\\ case\\ \\#9\\)\\ mitchell\\ stashower\\,\\ lt\\ mc\\ usnr\\)\ \(0\)\
\-\ patient\\ presented\\ with\\ a\\ 1\\ week\\ history\\	of\\ asymptomatic\\ yellowish\\ lesions\\ that\\ appeared\\ rapidly\\ on\\ his\\ trunk\\ and\\ spread\\ to\\ his\\ extremities\\.\\ his\\ past\\ medical\\ history\\ was\\ notable\\ for\\ pancreatitis\\ 5\\ years\\ ago\\,\\ atherosclerotic\\ peripheral\\ vascular\\ disease\\ and\\ depression\\.\\ patient\\'s\\ brother\\ had\\ a\\ history\\ of\\ pancreatitis\\ and\\ hyperlipidemia\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ his\\:\\ 0\\.33977413924569094\ \(0\)\
\-\ triglycerides\\:\\ 0\\.31045314994980244\ \(0\)\
\-\ gemfibrozil\\:\\ 0\\.2140323059385702\ \(0\)\
\-\ dropped\\:\\ 0\\.1780289170861859\ \(0\)\
\-\ lesions\\:\\ 0\\.16087708066651793\ \(0\)\
\-\ trunk\\:\\ 0\\.15591165022100817\ \(0\)\
\-\ was\\:\\ 0\\.1464377884521836\ \(0\)\
\-\ referral\\:\\ 0\\.14306419052898478\ \(0\)\
\-\ pancreatitis\\:\\ 0\\.13889261141694365\ \(0\)\
\-\ and\\:\\ 0\\.13023837821566203\ \(0\)\
\-\ resolved\\:\\ 0\\.12581885258489106\ \(0\)\
\-\ medicine\\:\\ 0\\.12345820517924111\ \(0\)\
\-\ started\\:\\ 0\\.11797929844023454\ \(0\)\
\-\ over\\:\\ 0\\.11681999325908131\ \(0\)\
\-\ under\\:\\ 0\\.11593855462395068\ \(0\)\
\-\ corneas\\:\\ 0\\.11199390271863306\ \(0\)\
\-\ 5582\\:\\ 0\\.11199390271863306\ \(0\)\
\-\ milky\\:\\ 0\\.11199390271863306\ \(0\)\
\-\ uppermost\\:\\ 0\\.11199390271863306\ \(0\)\
\-\ mitchell\\:\\ 0\\.11199390271863306\ \(0\)\
\-\ stashower\\:\\ 0\\.11199390271863306\ \(0\)\
\-\ were\\:\\ 0\\.10829598887091826\ \(0\)\
\-\ 1025\\:\\ 0\\.1070161529692851\ \(0\)\
\-\ extremities\\:\\ 0\\.10643916637517663\ \(0\)\
\-\ on\\:\\ 0\\.10575195907402057\ \(0\)\
\-\ skin\\:\\ 0\\.10419217001983401\ \(0\)\
\-\ eruptive\\:\\ 0\\.10348438331660081\ \(0\)\
\-\ yellowish\\:\\ 0\\.10074492994709754\ \(0\)\
\-\ the\\:\\ 0\\.09781525774681354\ \(0\)\
\-\ xanthoma\\:\\ 0\\.09661418094302542\ \(0\)\
\-\ fasting\\:\\ 0\\.09497486391456858\ \(0\)\
\-\ usnr\\:\\ 0\\.09497486391456858\ \(0\)\
\-\ internal\\:\\ 0\\.0943927631185775\ \(0\)\
\-\ elbows\\:\\ 0\\.09223541054506529\ \(0\)\
\-\ patient\\:\\ 0\\.09110953266411446\ \(0\)\
\-\ to\\:\\ 0\\.08753734928917321\ \(0\)\
\-\ brother\\:\\ 0\\.08725766079571731\ \(0\)\
\-\ following\\:\\ 0\\.08402320181939721\ \(0\)\
\-\ weeks\\:\\ 0\\.08394122083210555\ \(0\)\
\-\ buttocks\\:\\ 0\\.08312691179164518\ \(0\)\
\-\ lt\\:\\ 0\\.08255580223983516\ \(0\)\
\-\ lipid\\:\\ 0\\.08098643777352975\ \(0\)\
\-\ history\\:\\ 0\\.08026703474438075\ \(0\)\
\-\ surfaces\\:\\ 0\\.08004161466652464\ \(0\)\
\-\ papules\\:\\ 0\\.08004161466652464\ \(0\)\
\-\ profile\\:\\ 0\\.08004161466652464\ \(0\)\
\-\ layer\\:\\ 0\\.07795582511050408\ \(0\)\
\-\ cholesterol\\:\\ 0\\.07757805249048719\ \(0\)\
\-\ yellow\\:\\ 0\\.07685568876945763\ \(0\)\
\-\ hyperlipidemia\\:\\ 0\\.07685568876945763\ \(0\)\
\-\ fingers\\:\\ 0\\.07491322938997097\ \(0\)\
\-\ atherosclerotic\\:\\ 0\\.07491322938997097\ \(0\)\
\-\ soft\\:\\ 0\\.07456542104328442\ \(0\)\
\-\ mc\\:\\ 0\\.07350056448727098\ \(0\)\
\-\ knees\\:\\ 0\\.0729780753611561\ \(0\)\
\-\ depression\\:\\ 0\\.0729780753611561\ \(0\)\
\-\ erythematous\\:\\ 0\\.07108562273692866\ \(0\)\
\-\ seminar\\:\\ 0\\.07044495695689058\ \(0\)\
\-\ rapidly\\:\\ 0\\.07003569767831687\ \(0\)\
\-\ notable\\:\\ 0\\.07003569767831687\ \(0\)\
\-\ uniformed\\:\\ 0\\.06983607309391938\ \(0\)\
\-\ 1997\\:\\ 0\\.06925596636952516\ \(0\)\
\-\ appeared\\:\\ 0\\.06925596636952516\ \(0\)\
\-\ services\\:\\ 0\\.0687020389638952\ \(0\)\
\-\ dermatology\\:\\ 0\\.06852281473792299\ \(0\)\
\-\ after\\:\\ 0\\.0679458188770295\ \(0\)\
\-\ spread\\:\\ 0\\.06290942629244553\ \(0\)\
\-\ total\\:\\ 0\\.05738106222383006\ \(0\)\
\-\ collection\\:\\ 0\\.05654842852693663\ \(0\)\
\-\ tube\\:\\ 0\\.05595903655709159\ \(0\)\
\-\ there\\:\\ 0\\.05572978126030391\ \(0\)\
\-\ base\\:\\ 0\\.05327084272528054\ \(0\)\
\-\ course\\:\\ 0\\.05172821804314821\ \(0\)\
\-\ ago\\:\\ 0\\.051239751963589965\ \(0\)\
\-\ tender\\:\\ 0\\.05119629478036553\ \(0\)\
\-\ laboratory\\:\\ 0\\.050854066586971926\ \(0\)\
\-\ clear\\:\\ 0\\.05076997967302244\ \(0\)\
\-\ mm\\:\\ 0\\.050117247001520634\ \(0\)\
\-\ peripheral\\:\\ 0\\.0500775809203516\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.04767537501035095\ \(0\)\
\-\ week\\:\\ 0\\.04710278536432712\ \(0\)\
\-\ vascular\\:\\ 0\\.04623301367316566\ \(0\)\
\-\ white\\:\\ 0\\.04620409342082413\ \(0\)\
\-\ past\\:\\ 0\\.04558449837787189\ \(0\)\
\-\ medical\\:\\ 0\\.04450713947222011\ \(0\)\
\-\ clinical\\:\\ 0\\.044381994235217694\ \(0\)\
\-\ years\\:\\ 0\\.04292771630691556\ \(0\)\
\-\ abdomen\\:\\ 0\\.04273023256155771\ \(0\)\
\-\ for\\:\\ 0\\.04245137154649012\ \(0\)\
\-\ of\\:\\ 0\\.04111393535366262\ \(0\)\
\-\ presented\\:\\ 0\\.04083777993733028\ \(0\)\
\-\ blood\\:\\ 0\\.04067100035656122\ \(0\)\
\-\ significant\\:\\ 0\\.040434027388295164\ \(0\)\
\-\ physical\\:\\ 0\\.03797210658420236\ \(0\)\
\-\ upper\\:\\ 0\\.03742317705909699\ \(0\)\
\-\ noted\\:\\ 0\\.03713003127186786\ \(0\)\
\-\ posterior\\:\\ 0\\.03621333921682543\ \(0\)\
\-\ present\\:\\ 0\\.03593488798968507\ \(0\)\
\-\ lower\\:\\ 0\\.035785626072712066\ \(0\)\
\-\ exam\\:\\ 0\\.03525335332561124\ \(0\)\
\-\ case\\:\\ 0\\.0351825263516122\ \(0\)\
\-\ had\\:\\ 0\\.03489173489202317\ \(0\)\
\-\ non\\:\\ 0\\.0332280152943498\ \(0\)\
\-\ that\\:\\ 0\\.030390580228644708\ \(0\)\
\-\ disease\\:\\ 0\\.029396286527192627\ \(0\)\
\-\ an\\:\\ 0\\.026779401234140035\ \(0\)\
\-\ or\\:\\ 0\\.024362339495286066\ \(0\)\
\-\ no\\:\\ 0\\.02277309887303743\ \(0\)\
\-\ in\\:\\ 0\\.017421298127453595\ \(0\)\
\-\ with\\:\\ 0\\.01371283364007984\ \(0\)\
